In glioma, hypermethylation at CTCF and cohesin binding sites leads to loss of CTCF- binding at a TAD boundary, which aberrantly activates of oncogene PDGFRA through constant interactions with its enhancer (Flavahan et al. 2016). Here, CTCF is linked to glioma.